cytotoxic response
Recently Published Documents


TOTAL DOCUMENTS

231
(FIVE YEARS 23)

H-INDEX

31
(FIVE YEARS 4)

2022 ◽  
Vol 13 (1) ◽  
Author(s):  
Marine Charrier ◽  
Judith Lorant ◽  
Rafael Contreras-Lopez ◽  
Gautier Téjédor ◽  
Christophe Blanquart ◽  
...  

Abstract Background Muscular dystrophies (MDs) are inherited diseases in which a dysregulation of the immune response exacerbates disease severity and are characterized by infiltration of various immune cell types leading to muscle inflammation, fiber necrosis and fibrosis. Immunosuppressive properties have been attributed to mesenchymal stem cells (MSCs) that regulate the phenotype and function of different immune cells. However, such properties were poorly considered until now for adult stem cells with myogenic potential and advanced as possible therapeutic candidates for MDs. In the present study, we investigated the immunoregulatory potential of human MuStem (hMuStem) cells, for which we previously demonstrated that they can survive in injured muscle and robustly counteract adverse tissue remodeling. Methods The impact of hMuStem cells or their secretome on the proliferative and phenotypic properties of T-cells was explored by co-culture experiments with either peripheral blood mononucleated cells or CD3-sorted T-cells. A comparative study was produced with the bone marrow (BM)-MSCs. The expression profile of immune cell-related markers on hMuStem cells was determined by flow cytometry while their secretory profile was examined by ELISA assays. Finally, the paracrine and cell contact-dependent effects of hMuStem cells on the T-cell-mediated cytotoxic response were analyzed through IFN-γ expression and lysis activity. Results Here, we show that hMuStem cells have an immunosuppressive phenotype and can inhibit the proliferation and the cytotoxic response of T-cells as well as promote the generation of regulatory T-cells through direct contact and via soluble factors. These effects are associated, in part, with the production of mediators including heme-oxygenase-1, leukemia inhibitory factor and intracellular cell adhesion molecule-1, all of which are produced at significantly higher levels by hMuStem cells than BM-MSCs. While the production of prostaglandin E2 is involved in the suppression of T-cell proliferation by both hMuStem cells and BM-MSCs, the participation of inducible nitric oxide synthase activity appears to be specific to hMuStem cell-mediated one. Conclusions Together, our findings demonstrate that hMuStem cells are potent immunoregulatory cells. Combined with their myogenic potential, the attribution of these properties reinforces the positioning of hMuStem cells as candidate therapeutic agents for the treatment of MDs.


JCI Insight ◽  
2021 ◽  
Vol 6 (13) ◽  
Author(s):  
Soichi Sano ◽  
Ying Wang ◽  
Hayato Ogawa ◽  
Keita Horitani ◽  
Miho Sano ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Lorena Vigón ◽  
Daniel Fuertes ◽  
Javier García-Pérez ◽  
Montserrat Torres ◽  
Sara Rodríguez-Mora ◽  
...  

Infection by novel coronavirus SARS-CoV-2 causes different presentations of COVID-19 and some patients may progress to a critical, fatal form of the disease that requires their admission to ICU and invasive mechanical ventilation. In order to predict in advance which patients could be more susceptible to develop a critical form of COVID-19, it is essential to define the most adequate biomarkers. In this study, we analyzed several parameters related to the cellular immune response in blood samples from 109 patients with different presentations of COVID-19 who were recruited in Hospitals and Primary Healthcare Centers in Madrid, Spain, during the first pandemic peak between April and June 2020. Hospitalized patients with the most severe forms of COVID-19 showed a potent inflammatory response that was not translated into an efficient immune response. Despite the high levels of effector cytotoxic cell populations such as NK, NKT and CD8+ T cells, they displayed immune exhaustion markers and poor cytotoxic functionality against target cells infected with pseudotyped SARS-CoV-2 or cells lacking MHC class I molecules. Moreover, patients with critical COVID-19 showed low levels of the highly cytotoxic TCRγδ+ CD8+ T cell subpopulation. Conversely, CD4 count was greatly reduced in association to high levels of Tregs, low plasma IL-2 and impaired Th1 differentiation. The relative importance of these immunological parameters to predict COVID-19 severity was analyzed by Random Forest algorithm and we concluded that the most important features were related to an efficient cytotoxic response. Therefore, efforts to fight against SARS-CoV-2 infection should be focused not only to decrease the disproportionate inflammatory response, but also to elicit an efficient cytotoxic response against the infected cells and to reduce viral replication.


JCI Insight ◽  
2021 ◽  
Author(s):  
Eduardo Cepeda Cañedo ◽  
Stephanie Totten ◽  
Ryuhjin Ahn ◽  
Paul Savage ◽  
Deanna MacNeil ◽  
...  

2021 ◽  
Author(s):  
Mehmet Oguz ◽  
Berna Dogan ◽  
Serdar Durdagi ◽  
Asif Ali Bhatti ◽  
Serdar Karakurt ◽  
...  

Though quercetin is an effective bioactive compound preventing the progress of several human cancers, its impact is reduced due to low bioavailability. The therapeutic potential of quercetin can be enhanced...


2021 ◽  
Author(s):  
Aaron P. Havas ◽  
Ana A. Tula-Sanchez ◽  
Anvi Bhakta ◽  
Taylor Wingfield ◽  
Matthew J. Huntley ◽  
...  

2020 ◽  
Vol 9 (6) ◽  
pp. 14754-14770
Author(s):  
Leandro Antonio de Oliveira ◽  
Rejane Maria Pereira da Silva ◽  
Andrea Cecilia Dorion Rodas ◽  
Ricardo M. Souto ◽  
Renato Altobelli Antunes

Sign in / Sign up

Export Citation Format

Share Document